Efficacy and safety of the fixed combination Timolol 0,5%/Travoprost 0,004% compared the concomitant administration to the single components.

Phase 4

Recruiting

• Conditions: Primary open angle glaucoma; Ocular hypertension; Eye - Diseases / disorders of the eye

• Registration Number: ACTRN12612000247875
• Lead Sponsor: uigi Mazzeo,Md

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-02-28
• Last Update Posted: 2020-01-13

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Patients over 18 years with clinical diagnosis of primary open angle glaucoma or ocular hypertension who had been treated with any therapy

Exclusion Criteria

Abnormal corneal sensation, condition preventing tonometry, ocular opacity or insufficient dilation preventing retinal evaluation, narrow anterior chamber angle, inflammatory ocular surface disease, anterior/posterior uveitis, ocular inflammation/infection, progressive retinal disease, significant ocular signs/symptoms, allergic conjunctivitis, significant visual field defect or progressive visual field loss within the last year, history of certain ocular surgeries, significant cardiovascular disease, and history of pulmonary disease including asthma.

Study & Design

• Study Type: Interventional
• Study Design: Not specified